Interactions between glucocorticoids and cytokines in the bone microenvironment

Annals of the New York Academy of Sciences

Volumn 966, Issue , 2002, Pages 97-107

  Angeli, A ^a   Dovio, A ^a   Sartori, M L ^a   Masera, R G ^a   Ceoloni, B ^a   Prolo, P ^b   Racca, S ^a   Chiappelli, F ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glucocorticoid; Glucocorticoid receptor; IL 11; IL 6; Osteoblast; Osteoclast; Osteoporosis

Indexed keywords

CYTOKINE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR BETA; GLYCOPROTEIN GP 130; INTERLEUKIN 11; INTERLEUKIN 6; UNCLASSIFIED DRUG;

BONE ATROPHY; CONFERENCE PAPER; CYTOKINE PRODUCTION; HUMAN; ISOTOPE LABELING; LIGAND BINDING; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; RECEPTOR AFFINITY; SCATCHARD PLOT;

EID: 0036303323     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04207.x     Document Type: Conference Paper

References (47)

1. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
2. gp130 cytokine family and bone cells
3. Detection of direct binding of human herpesvirus 8-encoded interleukin-6 (vIL-6) to both gp130 and IL-6 receptor (IL-6R) and identification of amino acid residues of vIL-6 important for IL-6R-dependent and independent signaling
4. Novel neurotrophin-1/B cell-stimulating factor-3: A cytokine of the IL-6 family
5. Interleukin 6 and its receptor: Ten years later
6. Interleukin 6: The endocrine cytokine
7. Regulation of hypothalamic-pituitary-adrenal axis by cytokines: Actions and mechanism of action
8. Immune-neuro-endocrine interactions: Facts and hypotheses
9. Anti-inflammatory cytokines
10. Hematopoietic, immunomodulatory and epithelial effects of interleukin-11
11. Increased osteoclast development after estrogen loss: Mediation by interleukin-6
12. Interleukin-11: A new cytokine critical for osteoclast development
13. Glucocorticoid-induced osteoporosis
14. Molecular control of immune/inflammatory responses: Interactions between nuclear factor-κB and steroid receptor signaling pathways
15. Mechanism of action of glucocorticosteroid hormones: Possible implications for therapy of neuroimmunological disorders
16. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids
17. Nongenomic membrane actions of glucocorticoids in vertebrates
18. Mechanisms of glucocorticoid action in bone: Implications to glucocorticoid-induced osteoporosis
19. Inhibitory effect of physiological concentrations of cortisol but not estradiol on interleukin (IL)-6 production by human osteoblast-like cell lines with different constitutive IL-6 expression
20. The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro
21. Effects of cortisol on the expression of interleukin-6 and interleukin-1β in human osteoblast-like cells
22. Effects of dexamethasone on proliferation, activity, and cytokine secretion of normal human bone marrow stromal cells: Possible mechanisms of glucocorticoid-induced bone loss
23. Glucocorticoid receptor β: View I
24. Molecular identification and characterization of a and b forms of the glucocorticoid receptor
25. Low glucocorticoid receptor alpha/beta ratio in T-cell lymphoblastic leukemia
26. Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis
27. Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma
28. Colocalization of glucocorticoid and mineralocorticoid receptors in human bone
29. Regulation of osteoblast formation and function
30. Serum undercarboxylated osteocalcin is a marker of the risk of hip fractures in elderly women
31. Cortisol inhibits hepatocyte growth factor/scatter factor expression and induces c-met transcripts in osteoblasts
32. Transcriptional regulation of connective tissue growth factor by cortisol in osteoblasts
33. Sex steroids decrease and glucocorticoids increase the levels of gp130 protein in bone marrow-derived stromal cells: Correlation with altered IL-6 induced DNA-binding activity of Stat1 and Stat3 complexes
34. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors
35. A dual mechanism mediates repression of NF-κB activity by glucocorticoids
36. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases
37. Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: An autocrine switch from glucocorticoid inactivation to activation
38. Autocrine up-regulation of glucocorticoid receptors by interleukin-6 in human osteoblast-like cells
39. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production
40. IL-6 negatively regulates IL-11 production in vitro and in vivo
41. Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: Synergy with dexamethasone
42. Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy
43. Biomarkers of bone turnover after a short period of steroid therapy in elderly men
44. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
45. Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis
46. The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma
47. Multiple myeloma